Home » Costly Registration Requirement Discouraging Trials in Russia
Costly Registration Requirement Discouraging Trials in Russia
December 9, 2011
Mandatory local clinical trials required to register both novel and generic drugs in Russia are largely to blame for a decline in clinical trials there, according to a recent report by the Russia-based Association of Clinical Trials Organizations (ACTO).
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor